IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 192 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,425,790 | -52.4% | 1,394,163 | -47.4% | 0.04% | -49.3% |
| Q2 2023 | $28,192,276 | +75.8% | 2,649,650 | +73.8% | 0.07% | +54.3% |
| Q1 2023 | $16,034,805 | -18.3% | 1,524,221 | -3.8% | 0.05% | -25.8% |
| Q4 2022 | $19,634,260 | +1040.2% | 1,584,686 | +853.2% | 0.06% | +933.3% |
| Q3 2022 | $1,722,000 | -82.6% | 166,257 | -80.7% | 0.01% | -81.8% |
| Q2 2022 | $9,910,000 | -11.4% | 859,494 | -3.3% | 0.03% | 0.0% |
| Q1 2022 | $11,182,000 | +152.8% | 888,888 | +162.5% | 0.03% | +230.0% |
| Q3 2021 | $4,423,000 | +36.4% | 338,634 | +34.4% | 0.01% | +42.9% |
| Q2 2021 | $3,242,000 | -37.2% | 251,916 | -45.4% | 0.01% | -46.2% |
| Q1 2021 | $5,161,000 | -34.6% | 461,587 | -33.4% | 0.01% | -43.5% |
| Q4 2020 | $7,893,000 | +534.5% | 692,955 | +401.2% | 0.02% | +475.0% |
| Q3 2020 | $1,244,000 | -52.8% | 138,266 | -47.1% | 0.00% | -81.0% |
| Q1 2020 | $2,638,000 | -86.7% | 261,449 | -82.5% | 0.02% | -65.0% |
| Q4 2019 | $19,847,000 | +366.2% | 1,491,107 | +200.7% | 0.06% | +328.6% |
| Q3 2019 | $4,257,000 | +71.7% | 495,882 | +118.9% | 0.01% | +75.0% |
| Q2 2019 | $2,479,000 | -78.6% | 226,585 | -73.6% | 0.01% | -78.9% |
| Q1 2019 | $11,608,000 | +523.4% | 857,911 | +377.4% | 0.04% | +442.9% |
| Q4 2018 | $1,862,000 | -8.0% | 179,687 | +63.8% | 0.01% | +16.7% |
| Q3 2018 | $2,025,000 | -22.3% | 109,679 | -20.5% | 0.01% | -33.3% |
| Q2 2017 | $2,606,000 | -56.6% | 138,020 | -60.8% | 0.01% | -55.0% |
| Q1 2017 | $6,001,000 | +68.2% | 351,745 | +50.8% | 0.02% | +42.9% |
| Q4 2016 | $3,567,000 | +28.0% | 233,318 | +33.0% | 0.01% | +40.0% |
| Q3 2016 | $2,786,000 | -36.8% | 175,436 | -47.9% | 0.01% | -47.4% |
| Q2 2016 | $4,405,000 | +247.9% | 336,914 | +191.2% | 0.02% | +216.7% |
| Q1 2016 | $1,266,000 | -53.9% | 115,686 | -51.2% | 0.01% | -53.8% |
| Q4 2015 | $2,746,000 | +78.4% | 236,926 | +85.7% | 0.01% | +85.7% |
| Q2 2015 | $1,539,000 | +939.9% | 127,603 | +962.3% | 0.01% | +600.0% |
| Q1 2014 | $148,000 | +12.1% | 12,012 | +5.7% | 0.00% | 0.0% |
| Q4 2013 | $132,000 | -9.6% | 11,367 | -7.8% | 0.00% | 0.0% |
| Q3 2013 | $146,000 | -14.1% | 12,332 | -27.9% | 0.00% | 0.0% |
| Q2 2013 | $170,000 | – | 17,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |